Combination of Deferoxamine With Cyclosporine Synergistically Blunt Renal Cold Ischemia-Reperfusion Injury in Rat Transplantation Model
Transplantation Proceedings · 2024
DOI: 10.1016/j.transproceed.2024.08.035 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplantation Proceedings, 2024. Verfasst von Shaohua Wu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Tianjin Union Medical Center, Tianjin Medical University, Tianjin, China. Hauptthemen laut MEDLINE: Reperfusion Injury, Kidney Transplantation, Deferoxamine, Cyclosporine. Die Arbeit nennt 41 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVES: Ferroptosis plays a pivotal role in the pathogenesis of renal ischemia-reperfusion injury, where the processes are mediated by free ferrous ions and mitochondrial-released reactive oxygen species. However, the administration of high doses of cyclosporine A (CsA) or deferoxamine (DFO) poses a significant risk of renotoxicity. In contrast, low doses of DFO act as a ferrous iron chelator, and CsA functions as a mitochondrial reactive oxygen species blocker. This study aims to explore the potential protective effects of donor treatment with low-dose CsA, DFO, or their combination against ischemia-reperfusion injury during renal transplantation in a rat model. MATERIALS AND METHODS: In an ex vivo cold storage (CS) model utilizing renal slices, the impact of incorporating DFO, CsA, and a combination of both into the University of Wisconsin solution was assessed through the measurement of lactate dehydrogenase leakage. Additionally, their potential benefits were investigated in a rat donation after circulatory death (DCD) kidney transplant model, where the extent of damage was evaluated based on graft function, tubular necrosis, and inflammation. RESULTS: The co-administration of DFO and CsA effectively decreased the release of lactate dehydrogenase induced by CS ( P ≥ .05). In the in vivo model, this combined supplementation demonstrated a mitigating effect on reperfusion injury, evidenced by lower blood urea nitrogen levels and acute tubular necrosis scores compared to the control group (allP ≤ .05). Furthermore, the combined treatment significantly reduced apoptotic levels compared to the control group (P ≥ .05). CONCLUSIONS: The combined treatment with DFO and CsA mitigated the cold ischemia-reperfusion injury in the DCD kidney. Hence, this presents a new strategy for the CS of DCD kidney in clinical transplants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Tianjin Union Medical Center, Tianjin Medical University, Tianjin, China.
- Tianjin First Center Hospital, Tianjin, China.
- Tianjin Union Medical Centre, Tianjin, China. Electronic address: lr3595@163.com.
Zitieren
APA
Wu, S., Qian, H., Zou, X., & Liu, R. (2024). Combination of Deferoxamine With Cyclosporine Synergistically Blunt Renal Cold Ischemia-Reperfusion Injury in Rat Transplantation Model. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2024.08.035
Vancouver
Wu S, Qian H, Zou X, Liu R. Combination of Deferoxamine With Cyclosporine Synergistically Blunt Renal Cold Ischemia-Reperfusion Injury in Rat Transplantation Model. Transplantation Proceedings. 2024. doi:10.1016/j.transproceed.2024.08.035
BibTeX
@article{Wu2024,
author = {Wu, Shaohua and Qian, Huaying and Zou, Xunfeng and Liu, Rui},
title = {Combination of Deferoxamine With Cyclosporine Synergistically Blunt Renal Cold Ischemia-Reperfusion Injury in Rat Transplantation Model},
journal = {Transplantation Proceedings},
year = {2024},
doi = {10.1016/j.transproceed.2024.08.035}
}
EUVIMED